21 July 2020 · This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing Tissue Engineered Products.
12 July 2022 · This document provides expert clinical pharmacy guidance on supportive medicines in order to facilitate the treatment of complex CAR-T Cell Therapy patients.
21 July 2020 · This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing Somatic Cell Therapy Product.
6 February 2024 · Practical advice for centres implementing Gene Therapies detailing GMSC and Governance requirements and optimal preparation location.
27 September 2019 · Regulatory export requirements for hospitals procuring (harvesting) patient’s own cells/tissues for use as starting materials in the manufacture of ATMPs.
20 August 2021 · This guidance provides advice for ATMP developers, highlighting implementation challenges faced by the NHS and suggesting design consideration to minimise them.
2 October 2018 · This document outlines key areas where Chief Pharmacists should focus pharmaceutical expertise prior to an organisation implementing CAR-T Therapy.